Diagnostic Value and Safety of Flecainide Infusion Test in Brugada Syndrome
Status:
Completed
Trial end date:
2017-07-26
Target enrollment:
Participant gender:
Summary
The study aims to use flecainide infusion test as diagnostic test to unmask concealed Brugada
Syndrome cases. It proposes to assess the safety profile of this test in US patients and its
higher sensitivity when compared to procainamide infusion (the conventional drug used in the
USA). As a substudy it proposes to apply this test to early ARVC cases in order to evaluate
if ECG changes similar to those seen in Brugada Syndrome could be unmasked by flecainide iv.
Details
Lead Sponsor:
New York University School of Medicine NYU Langone Health